SAN DIEGO, March 29 /PRNewswire-FirstCall/ -- Cadence Pharmaceuticals, Inc. announced today the appointment of Michael L. Eagle to the company’s board of directors.
Mr. Eagle served as Vice President of Manufacturing for Eli Lilly and Company from 1994 through 2001 and held a number of executive management positions with Eli Lilly and its subsidiaries throughout his career. Since retiring from Eli Lilly, he has served as a founding member of Barnard Life Sciences, LLC. Mr. Eagle currently serves on the boards of directors of Somaxon Pharmaceuticals, Inc., a publicly-held specialty pharmaceutical company, Micrus Endovascular Corporation, a publicly-held medical device company, and Cardio Polymers, Inc., formerly known as Symphony Medical, a private medical device company. He serves on the Board of Trustees of the La Jolla Playhouse and Futures for Children. Mr. Eagle earned a B.S. degree in mechanical engineering from Kettering University and an M.B.A. from the Krannert School of Management at Purdue University.
Cadence(TM) is a trademark of Cadence Pharmaceuticals, Inc.
CONTACT: William R. LaRue, SVP & Chief Financial Officer of Cadence
Pharmaceuticals, Inc., +1-858-436-1400; or Aimee Corso, Media & Investor
Relations of WCG, +1-310-780-2661, for Cadence Pharmaceuticals, Inc.
Web site: http://www.cadencepharm.com/
